Brainstorm Cell Therapeutics In

Q4 2020 13F Holders

Symbol
BCLI
CUSIP
10501E201
Type
Equity
Class
COM NEW
Num filings
107
Total reported value, excl. options
$40.4 M
Manager Report Date Value ($000) Shares Option Type